ææ°ã® Amgen Inc ã®æ ªåŒãã¥ãŒã¹ã決ç®ãã¢ããªã¹ãè©äŸ¡ãéèŠãªååã远跡ã§ããŸãã
11æ5æ¥ã®Amgen Inc (AMGN) çµå€ã¯3.80%äžèœïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
10æ15æ¥ã®Amgen Inc (AMGN) å€åãã¯3.01%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
10æ14æ¥ã®Amgen Inc (AMGN) å€åãã¯3.29%äžæïŒå€åãã®èåŸã«ããèŠå
10æ7æ¥ã®Amgen Inc (AMGN) å€åãã¯3.06%äžæïŒå®å šãªåæ
10æ1æ¥ã®Amgen Inc (AMGN) çµå€ã¯3.38%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
9æ22æ¥ã®Amgen Inc (AMGN) å€åãã¯3.90%äžæïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
9æ8æ¥ã®Novo Nordisk A/S (NVO) çµå€ã¯3.09%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
9æ8æ¥ã®Bristol-Myers Squibb Co (BMY) å€åãã¯3.25%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
9æ8æ¥ã®Vertex Pharmaceuticals Inc (VRTX) å€åãã¯3.06%äžèœïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
9æ8æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.26%äžèœïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã